Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02375204 |
Recruitment Status :
Active, not recruiting
First Posted : March 2, 2015
Last Update Posted : March 17, 2023
|
Sponsor:
Alliance for Clinical Trials in Oncology
Collaborators:
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Movember Foundation
Institute of Cancer Research (ICR), United Kingdom
Cancer Research UK
UNICANCER
Irish Group CTI
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | June 2024 |
Estimated Study Completion Date : | June 2024 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):